Accendra Health Completes $1 Billion Debt Exchange Amid High Participation
Event summary
- Accendra Health exchanged $1.026 billion in new notes for existing debt, with 99.9% of 2029 Notes and 99.2% of 2030 Notes tendered by June 23, 2026.
- The company issued $539.25 million in First Lien Notes, including $326.25 million as new money.
- Total principal exchanged included $478.3 million of 2029 Notes and $548.0 million of 2030 Notes.
- The exchange was conducted under Rule 144A and Regulation S, targeting qualified institutional buyers and non-U.S. persons.
The big picture
This near-complete exchange reflects strong creditor support for Accendra Health's restructuring efforts amid a challenging healthcare services landscape. The transaction suggests confidence in the company's long-term strategy, though investors should monitor how the new capital structure affects operational flexibility and growth prospects.
What we're watching
- Leverage Dynamics
- How the new debt structure will impact Accendra Health's leverage ratios and credit metrics.
- Execution Risk
- Whether the company can maintain high participation rates in future liability management exercises.
- Market Conditions
- The pace at which interest rates will affect the cost of Accendra Health's outstanding debt.